). No bacteria were observed on CSF Gram staining. A set of two blood cultures performed on admission, before receiving antibiotics, was positive. Direct examination by Gram staining showed Gram-positive cocci organized into chains subsequently identified as Streptococcus australis strain CNRCCH2009401. A second set of blood cultures was performed 4 h after initial antibiotic treatment and remained sterile. CSF solid culture remained negative, as did the Schaedler broth inoculated with the CSF, even after 10 days of incubation. The CSF sample was tested by broad-range 16S rRNA gene PCR combined with sequencing, which yielded Streptococcus species secondly identified as S. australis by sodA gene sequencing. On the basis of antibiotic susceptibility testing conducted on the blood culture isolate, cefotaxime was stopped and amoxicillin was administered i.v. for 1 week. The patient's status improved rapidly. Results from the cerebral CT scan and transthoracic echocardiography were normal. According to Duke criteria, a diagnosis of infective endocarditis was eliminated. Follow-up visits showed a healthy patient with no clinical signs of relapse.
Microbiological findings
The S. australis strain grew as a-haemolytic colonies on both horse and sheep blood agar (Oxoid) incubated for 18 h at 37 u C under aerobic and anaerobic conditions. We observed Gram-positive, catalase-negative cocci organized into small chains. Biochemical characteristics of the strain obtained with the Rapid ID 32 STREP system (bioMérieux) (profile 44012441100) corresponded to Streptococcus oralis or Streptococcus mitis with accuracies of 56.1 % and 43.5 %, respectively. Vitek II identification performed with a GP card (bioMérieux) resulted in the strain being identified as S. oralis or S. mitis as well (profile 065510364351011) with accuracies of 93 %. Antibiotic susceptibility testing was performed on Mueller-Hinton sheep blood agar (Oxoid) using the disc diffusion method and MICs were determined with the Etest (AES). The Antibiogram Committee of the French Society for Microbiology criteria for Streptococcus species were used for the interpretation of antimicrobial drug susceptibility (http://www.sfm-microbiologie.org). Strain CNRCCH2009401 was susceptible to b-lactams (MICs of benzylpenicillin, amoxicillin and cefotaxime ,0.016 mg ml 21 ), tetracycline, erythromycin, pristinamycin, clindamycin, rifampicin, fosfomycin, gentamicin (disc concentration of 500 mg), kanamycin (disc concentration of 1000 mg), vancomycin and teicoplanin. Universal 16S rRNA gene amplification was performed on CSF to confirm bacterial meningitis. DNA extraction was performed with the QIAamp DNA Mini kit (Qiagen), and PCR was performed with the universal prokaryotic primers F8-27 (59-AGAGTTTGATCCTGGCTCAG-39) (Koort et al., 2005) and RU2 [59-TACGG(T/C)TACCTTGTTACGACTTC-39]; these primers were adapted from those used by Lu et al. (2000) to amplify a segment of approximately 1500 bp corresponding to part of the 16S rRNA gene. Semi-nested PCR with the primers U1 (59-CCAGCAGCCGCGGTAAT-ACG-39) and RU2 (Lu et al., 2000 ) generated a 996 bp segment, which was sequenced. BLAST sequence analysis yielded 98 % identity with sequences for streptococcal species that belong to the Streptococcus mitis group, such as S. oralis, Streptococcus sanguinis, Streptococcus parasanguinis, S. mitis, Streptococcus infantis, Streptococcus pneumoniae and Streptococcus pseudopneumoniae (NCBI and BIBI databases). Accurate identification at the species level was performed by sodA gene amplification and sequencing, as previously described (Poyart et al., 1998) . Sequence analysis yielded 97 % identity with the sequence for the S. australis type strain CIP 107167 (GenBank accession no. DQ132987). Identical results were obtained with the blood culture isolate. Table 1 . Phenotypic characteristics of the Streptococcus australis isolate from this study compared with those of S. australis isolates described previously
The S. australis isolate from this study was compared to those described in previous reports (Willcox et al., 2001; Hoshino et al., 2005) . +, 85 % or more of the strains tested positive; 2, 15 % or less of the strains tested positive; v, 16-84 % of the strains tested positive. All the strains were typed by the Rapid ID 32 STREP system (bioMérieux). ND, Not determined. 
Discussion
S. australis, an oral streptococcal species, was first described in 2001 from strains isolated during a microbiological survey of saliva samples from healthy children attending the United Hospital in Sydney, Australia (Willcox et al., 2001) . S. australis belongs to the S. mitis group, one of the five groups of viridans streptococci described by Facklam (2002) . Standard biochemical phenotypic identification, such as the Rapid ID 32 STREP system (bioMérieux), showed that isolate CNRCCH2009401 resembled S. oralis and S. mitis. Comparing isolate CNRCCH2009401 with the S. australis isolates described by Willcox et al. (2001) and Hoshino et al. (2005) , we noted that, even though the Rapid ID 32 STREP system (bioMérieux) was employed in all three studies, there were differences in the phenotypic characteristics (Table 1) . Therefore, phenotypic characterization is of limited value during the identification of several viridans streptococci species (Hoshino et al., 2005; Jacobs et al., 1995) . Phylogenetic analysis based on 16S rRNA gene sequencing confirmed that isolate CNRCCH2009401 belongs to the S. mitis group. There is significant sequence conservation of the 16S rRNA gene; thus, this molecular tool is not appropriate for accurate identification in this group of streptococci (Hoshino et al., 2005; Kawamura et al., 1999; Matta et al., 2009; Poyart et al., 1998) . The sodA gene has been identified as a valuable target housekeeping gene for sequence-based identification, as the results obtained with this gene are consistent with conclusive identification (Poyart et al., 1998) . In this study, sodA gene sequence typing identified isolate CNRCCH2009401 as S. australis with 97 % identity with the type strain, CIP 107167. Remarkably, sodA gene sequences of S. pneumoniae, S. mitis and S. oralis shared between 93 % and 94 % identity with the sequence of the S. australis type strain. Therefore, unambiguous sodA sequences are essential to conduct an accurate molecular diagnosis of S. australis. Finally, diagnosis of S. australis must be the result of a combination of both phenotypic and molecular robust arguments.
Members of the S. mitis group are some of the most frequently isolated non-b-haemolytic streptococci in bacteraemic patients (Hoshino et al., 2005) . These species are usually responsible for subacute endocarditis (Hoshino et al., 2005) , but are rarely responsible for communityacquired meningitis (Cabellos et al., 1999) . The few cases of meningitis reported to be due to these streptococcal species were associated with either an iatrogenic origin (Idigoras et al., 2001; Legrand et al., 2007; Yaniv & Potasman, 2000) , such as dental manipulation, invasive spine investigation, spinal anaesthesia and gastrointestinal endoscopy, or an underlying disease (Hoshino et al., 2005; Idigoras et al., 2001; Jacobs et al., 1995; Yaniv & Potasman, 2000) , such as neutropenia and malignancy. For most of the cases of community-acquired acute meningitis caused by S. mitis group streptococci, co-morbidities have been suggested (Kutlu et al., 2008; Møller et al., 1999) . In our case, the patient presented no surgical or traumatic history; the predisposing factors were old age and an untreated monoclonal gammopathy of undetermined significance. Considering these underlying conditions, it appears that our patient presented initial pneumonia complicated with secondary meningitis by haematogen diffusion. Negative-CSF culture can be explained by preliminary antibiotherapy and low inoculum density.
In conclusion, we report to the best of our knowledge the first documented case of an invasive S. australis infection resulting in meningitis. The molecular diagnostic approach in this study should be useful for assessing the occurrence of S. australis in other human infections, which, in the past, have primarily been thought to be due to S. mitis or S. oralis isolates. Nevertheless, even in the age of molecular tools, it remains extremely difficult to make an accurate identification of viridans streptococci.
